06/26/2024
7:32 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/17/2024
3:41 PM | Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/06/2024
7:03 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
7:06 AM | Lyell Immunopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/06/2024
7:12 AM | Lyell Immunopharma (Filer)
| Form 424B5 | |
05/05/2024
11:15 PM | Lyell Immunopharma (Filer)
| Form EFFECT | |
04/22/2024
3:15 PM | Lyell Immunopharma (Filer)
| Form DEF 14A | |
|
04/22/2024
3:16 PM | Lyell Immunopharma (Filer)
| Form DEFA14A | |
04/22/2024
3:17 PM | Lyell Immunopharma (Filer)
| Form ARS | |
02/14/2024
2:18 PM | ARCH Venture Fund IX, L.P. (Filed by)
Lyell Immunopharma (Subject)
| Form SC 13G/A | |
02/13/2024
7:22 PM | Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:24 PM | Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:25 PM | Lang Matthew (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:17 PM | Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:19 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Lyell Immunopharma (Subject)
| Form SC 13G | |
11/20/2023
7:53 PM | Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:54 PM | Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:55 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:52 PM | Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:26 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:14 PM | Lyell Immunopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/11/2023
8:16 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
3:20 PM | Bishop Hans Edgar (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:22 PM | BRAWLEY OTIS W (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:23 PM | Lyell Immunopharma (Issuer)
NABEL ELIZABETH G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:24 PM | Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:26 PM | FRIEDMAN CATHY (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:27 PM | Lyell Immunopharma (Issuer)
RIEFLIN WILLIAM JL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
